Prosecution Insights
Last updated: November 20, 2026
Application No. 17/418,376

MEDICAMENT DELIVERY DEVICE

Non-Final OA §102§103
Filed
Jun 25, 2021
Priority
Jan 11, 2019 — provisional 62/791,443 +2 more
Examiner
MARRISON, SAMUEL JOSEPH
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Shl Medical AG
OA Round
9 (Non-Final)
68%
Grant Probability
Favorable
9-10
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
37 granted / 54 resolved
-1.5% vs TC avg
Strong +36% interview lift
Without
With
+35.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
41 currently pending
Career history
104
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
52.8%
+12.8% vs TC avg
§102
23.7%
-16.3% vs TC avg
§112
18.9%
-21.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 54 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 31 August 2026 has been entered. Response to Amendment Applicant has amended claims 10, 16, 19, and 25. Claims 10 and 13-25 remain pending. Response to Arguments Applicant's arguments filed 31 August 2026 have been fully considered but they are not persuasive. Applicant has argued that Hogdahl does not disclose the longitudinal groove as newly claimed. Examiner respectfully disagrees. Hogdahl discloses a plunger rod (plunger rod 112, fig. 2), wherein the plunger rod is arranged with a longitudinal groove (the hollowed out interior of plunger rod 112 is a longitudinal groove which extends proximally from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112, see fig. 9), wherein the longitudinal groove is arranged parallel to a longitudinal axis of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends in parallel to a longitudinal axis of the plunger rod) and extends proximally from a distal termination at a distal most end of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends along the longitudinal axis from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112). Examiner notes that this interpretation of the longitudinal groove is different to that which was relied upon for the previous rejections in view of Hogdahl, and that the relied upon groove meets the broadest reasonable interpretation of a “groove” where Merriam Webster defines a groove to be “a long narrow channel or depression”, and the hollowed out interior of plunger rod 112 is a long, narrow channel which extends along the interior of the plunger rod. Thus, Applicant’s arguments are respectfully found unpersuasive in view of the new interpretation of Hogdahl as relied upon below. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 10, 13, 14, 17, and 19-23 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hogdahl (US 20180185583, henceforth Hogdahl, previously made of reference). Regarding claim 10, Hogdahl discloses a medicament delivery device (medicament delivery device 10, fig. 1) comprising: a housing (proximal housing part 16 and distal housing part 18, fig. 1) arranged to accommodate a medicament container (medicament container 26, fig. 1; housing parts 16 and 18 are arranged to accommodate the container where they hold the container in the assembled device, see [0027]); a power pack (power unit 64, fig. 2) arranged to exert a force on the medicament container for expelling a dose of medicament ([0036]), where the power pack comprises: a plunger rod (plunger rod 112, fig. 2), wherein the plunger rod is arranged with a longitudinal groove (the hollowed out interior of plunger rod 112 is a longitudinal groove which extends proximally from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112, see fig. 9), wherein the longitudinal groove is arranged parallel to a longitudinal axis of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends in parallel to a longitudinal axis of the plunger rod) and extends proximally from a distal termination at a distal most end of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends along the longitudinal axis from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112); a drive spring (drive spring 114, fig. 2) arranged to exert a force on the plunger rod ([0048]); an actuator (actuator 90, fig. 2) coaxial with the plunger rod (see [0036] and [0041]) and arranged with holding elements (tongues 94 and ledges 100, fig. 4, see also [0033]) for releasably holding the plunger rod with the drive spring in an energized state (see Abstract, [0042], [0046]), wherein the holding elements of the actuator comprise two proximally directed arms (flexible tongues 94, fig. 4, where the two selected arms are the arm which is fully shown in the figure and labeled as 94 and the arm diametrically opposed to it where ledge 100 is called out) between two oppositely arranged slits (cut-outs 92, fig. 4, where the two selected cut-outs equivalent to the claimed slits are the slit called out as 92 in fig. 4 and the slit diametrically opposed to it, thus making them oppositely arranged as claimed), wherein the two oppositely arranged slits are widened in the proximal direction (see fig. 4, the distal most ends of cut-outs 92 are rounded as shown, meaning that the cut-outs widen in the proximal direction at least over the curved distal end portion of the slits) such that the two proximally directed arms are flexible in the generally radial direction (see [0033], tongues 94 are radially flexible sine they are free at their respective proximal ends; see also [0041] which mentions radial flexing); and an actuator sleeve (actuator sleeve 76, fig. 2) coaxial with the actuator (see [0033]) and arranged to interact with the holding elements (see Abstract), the actuator sleeve being movable in a longitudinal direction in relation to the actuator ([0033]), a medicament delivery member guard (medicament delivery member guard 34, fig. 1) protruding from the proximal end of the housing (see [0028] and especially [0045]) and movable in the longitudinal direction ([0045]), the medicament delivery member guard being connected to the actuator sleeve ([0031]); a manually operable activator (activator unit 124, see figs. 2 and 6, where activator unit 124 includes outer tubular first part 126 and second part 134) arranged at a distal end of the housing (see figs. 3 and 8, the distal end of the housing is called out as distal housing part 18, [0037]) movable in the longitudinal direction ([0046] and [0047]) and operably connected to the actuator for releasing the plunger rod ([0046]), a locking arrangement (the arrangement of power pack 64 is considered to be a locking arrangement as claimed as indicated further below; since it meets all of the claim limitations functionally and structurally, it is the claimed locking arrangement) for releasably locking the actuator to the actuator sleeve (see Abstract) such that movement of the medicament delivery member guard in a distal direction causes the actuator sleeve, the actuator and the plunger rod to move in a distal direction with the medicament delivery member guard due to the locking arrangement (see [0045] and [0046], when the medicament delivery device is assembled, it can be moved in the distal direction which is the direction toward activator unit 124 relative to a user where it is in the holding state such that the claimed structures move together as claimed relative to the user who is moving the device), wherein the manual movement of the activator ([0046]) causes a movement of the plunger rod and the actuator in relation to the actuator sleeve in a proximal direction ([0046] and [0048]) to cause a release of the plunger rod by the actuator ([0046], [0048]-[0049], the plunger rod is released from its engagement with holding element 66 which allows it to act on stopper 28, and this is caused by movement of the activator which causes a movement of the plunger rod and the actuator as claimed) wherein the locking arrangement comprises a flexible member on the actuator (the flexible member on actuator 90 is the combination of ledges 104 which turn into and thus include radially flexible arms 106 and ledges 108, see [0035] and fig. 4, and stop element 102 which includes proximally directed stop ledge 102a and distally directed ledge 102b, fig. 4 and [0034]) provided with a proximally directed stop surface (proximally directed ledge 102a, fig. 4), on which a distally directed surface of the actuator sleeve (the surface at the distal end of cut-out 88, figs. 4 and 5, is distally directed as it faces toward activator 124 in the assembled device) will act during movement in the distal direction (see [0041], once the power pack 64 is assembled, stop ledges 102 are in direct contact with the surfaces of cut-outs 88), preventing relative movement of the actuator in relation to the actuator sleeve in a proximal direction (see [0041], the engaged surfaces are meant to prevent excess relative proximal movement), and that the activator is arranged with ledges (inwardly directed ledge 150, fig. 6b) acting on the flexible member (see [0043], ledge 150 engages ledge 108 which is a part of the flexible member as called out above), removing the contact between the stop surface and the surface of the actuator sleeve (see [0046], the actuator 90 and the stop surface thereof is longitudinally moved relative to actuator sleeve 76, and thus the previous direct contact between the called out faces ends since they are no longer in the same location along the longitudinal axis of the device), enabling movement of the actuator and the plunger rod (see [0046] and [0048], actuator 90 and plunger rod 112 can move further once the actuator 90 is not in direct contact with actuator sleeve 76 as a result of user input), and wherein the activator further comprises a proximally directed member (proximally directed arms 152, fig. 6b) spaced from the ledges of the activator (see fig. 6b, there is a radial gap between ledges 150 and proximally directed arms 152 which shows that they are spaced from each other) that directly contacts a distal end of the plunger rod (see [0046], “the proximal direction the proximally directed arms 152 will act on the distal end of the plunger rod 112 and push it in the proximal direction”) when the activator is depressed proximally in the longitudinal direction (see [0046]), wherein the proximally directed member of the activator has a proximal length as measured from a proximal most end to a distal most end of the proximally directed member that is less than a proximal length of the ledges of the activator as measured from a proximal most end to a distal most end of the ledges (see annotated fig. 6b, the called out lengths are measured from the same distal most end point which is a flat plate from which the ledges 150 and arms 152 extend and the ledges are shown as having a greater length than the arms), and wherein the proximally directed member is designed to act on the distal end of the plunger rod for enabling movement in the proximal direction of the plunger rod and the actuator (see [0046]). PNG media_image1.png 394 366 media_image1.png Greyscale Annotated fig. 6b from Hogdahl calling out the lengths of the ledges and arms of the activator Regarding claim 13, Hogdahl discloses the medicament delivery device further comprising a driver (holding element 66, fig. 4) operably connected between the plunger rod and a medicament container holder (medicament container holder 52, fig. 2; holding element 66 is operable connected between the elements as claimed as disclosed in [0042] and [0044] where it is operable connected to each of them and is shown as being longitudinally between the elements in figs. 1 and 3) such that movement of the plunger rod in the proximal direction will cause the driver and thus the medicament container holder to move in a proximal direction, causing a penetration operation ([0048]). Regarding claim 14, Hogdahl discloses the medicament delivery device wherein the driver has a releasable connection to the plunger rod such that the plunger rod is released from the driver when a penetration operation has ended ([0049]), enabling the plunger rod to continue in the proximal direction ([0049]), acting on a stopper of the medicament container (stopper 28, fig. 1 and [0049]) and causing an injection operation ([0049]). Regarding claim 17, Hogdahl discloses the medicament delivery device wherein the power pack comprises a guide rod (guide rod 120, fig. 2) provided with fastening elements at its distal end (ledges 118, fig. 2), in which the fastening elements engage cut-outs on the actuator (cut-outs 109, fig. 4; the claimed engagement is disclosed in [0036]), and wherein the drive spring is arranged between a proximal end wall of the plunger rod and the fastening elements (the claimed proximal end wall is proximal wall 116; the claimed arrangement is disclosed in [0036]). Regarding claim 19, Hogdahl discloses a medicament delivery device (medicament delivery device 10, fig. 1) comprising: a housing (proximal housing part 16 and distal housing part 18, fig. 1); a medicament container (medicament container 26, fig. 1) positioned within the housing (housing parts 16 and 18 hold the container in the assembled device, see [0027]); a power pack (power unit 64, fig. 2) operatively arranged to exert a force on the medicament container for expelling a dose of medicament ([0036]), where the power pack comprises: a plunger rod (plunger rod 112, fig. 2), wherein the plunger rod is arranged with a longitudinal groove (the hollowed out interior of plunger rod 112 is a longitudinal groove which extends proximally from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112, see fig. 9), wherein the longitudinal groove is arranged parallel to a longitudinal axis of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends in parallel to a longitudinal axis of the plunger rod) and extends proximally from a distal termination at a most end of the plunger rod (see fig. 9, the hollow interior of plunger rod 112 extends along the longitudinal axis from the distal most end of plunger rod 112 in the proximal direction along the interior of plunger rod 112); a drive spring (drive spring 114, fig. 2) positioned inside the plunger rod (see fig. 3, drive spring 114 is shown inside of plunger rod 112); a guide rod (guide rod 120, figs. 2 and 3) positioned inside the drive spring (see fig. 3, guide rod 120 is shown inside of drive spring 114); an actuator (actuator 90, fig. 2) positioned around the plunger rod (see [0036] and [0041] and see fig. 7) having holding elements (tongues 94 and ledges 100, fig. 4, see also [0033]) that releasably hold the plunger rod axially fixed relative to the housing when the drive spring in an energized state (see Abstract, [0042], [0046]), wherein the holding elements of the actuator comprise two proximally directed arms (flexible tongues 94, fig. 4, where the two selected arms are the arm which is fully shown in the figure and labeled as 94 and the arm diametrically opposed to it where ledge 100 is called out) between two oppositely arranged slits (cut-outs 92, fig. 4, where the two selected cut-outs equivalent to the claimed slits are the slit called out as 92 in fig. 4 and the slit diametrically opposed to it, thus making them oppositely arranged as claimed), wherein the two oppositely arranged slits are widened in the proximal direction (see fig. 4, the distal most ends of cut-outs 92 are rounded as shown, meaning that the cut-outs widen in the proximal direction at least over the curved distal end portion of the slits) such that the two proximally directed arms are flexible in the generally radial direction (see [0033], tongues 94 are radially flexible sine they are free at their respective proximal ends; see also [0041] which mentions radial flexing); and an actuator sleeve (actuator sleeve 76, fig. 2) positioned relative to the actuator to operatively interact with the holding elements (see [0033] and see Abstract), where the actuator sleeve moves in a longitudinal direction in relation to the actuator ([0033]), a medicament delivery member guard (medicament delivery member guard 34, fig. 1) that protrudes from a proximal end of the housing (see [0028] and especially [0045]) and movable in the longitudinal direction ([0045]), the medicament delivery member guard being connected to the actuator sleeve ([0031]); and a manually operable activator (activator unit 124, see figs. 2 and 6, where activator unit 124 includes outer tubular first part 126 and second part 134) arranged at a distal end of the housing (see figs. 3 and 8, the distal end of the housing is called out as distal housing part 18, [0037]) that moves in the longitudinal direction ([0046] and [0047]) and is operably connected to the actuator to release the plunger rod ([0046]), and a locking arrangement (the arrangement of power pack 64 is considered to be a locking arrangement as claimed as indicated further below; since it meets all of the claim limitations functionally and structurally, it is the claimed locking arrangement) for releasably locking the actuator to the actuator sleeve (see Abstract) such that movement of the medicament delivery member guard in a distal direction causes the actuator sleeve, the actuator and the plunger rod to move in a distal direction with the medicament delivery member guard due to the locking arrangement (see [0045] and [0046], when the medicament delivery device is assembled, it can be moved in the distal direction which is the direction toward activator unit 124 relative to a user where it is in the holding state such that the claimed structures move together as claimed relative to the user who is moving the device), and wherein the manual movement of the activator ([0046]) causes a movement of the plunger rod and the actuator in relation to the actuator sleeve in a proximal direction ([0046] and [0048]) to cause a release of the plunger rod by the actuator ([0046], [0048]-[0049], the plunger rod is released from its engagement with holding element 66 which allows it to act on stopper 28, and this is caused by movement of the activator which causes a movement of the plunger rod and the actuator as claimed), wherein the locking arrangement comprises a flexible member on the actuator (the flexible member on actuator 90 is the combination of ledges 104 which turn into and thus include radially flexible arms 106 and ledges 108, see [0035] and fig. 4, and stop element 102 which includes proximally directed stop ledge 102a and distally directed ledge 102b, fig. 4 and [0034]) provided with a proximally directed stop surface (proximally directed ledge 102a, fig. 4), on which a distally directed surface of the actuator sleeve (the surface at the distal end of cut-out 88, figs. 4 and 5, is distally directed as it faces toward activator 124 in the assembled device) will act during movement in the distal direction (see [0041], once the power pack 64 is assembled, stop ledges 102 are in direct contact with the surfaces of cut-outs 88), preventing relative movement of the actuator in relation to the actuator sleeve in a proximal direction (see [0041], the engaged surfaces are meant to prevent excess relative proximal movement), and that the activator is arranged with ledges (inwardly directed ledge 150, fig. 6b) acting on the flexible member (see [0043], ledge 150 engages ledge 108 which is a part of the flexible member as called out above), removing the contact between the stop surface and the surface of the actuator sleeve (see [0046], the actuator 90 and the stop surface thereof is longitudinally moved relative to actuator sleeve 76, and thus the previous direct contact between the called out faces ends since they are no longer in the same location along the longitudinal axis of the device), enabling movement of the actuator and the plunger rod (see [0046] and [0048], actuator 90 and plunger rod 112 can move further once the actuator 90 is not in direct contact with actuator sleeve 76 as a result of user input), and wherein the activator further comprises a proximally directed member (proximally directed arms 152, fig. 6b) spaced from the ledges of the activator (see fig. 6b, there is a radial gap between ledges 150 and proximally directed arms 152 which shows that they are spaced from each other) that directly contacts a distal end of the plunger rod (see [0046], “the proximal direction the proximally directed arms 152 will act on the distal end of the plunger rod 112 and push it in the proximal direction”) when the activator is depressed proximally in the longitudinal direction (see [0046]), wherein the proximally directed member of the activator has a proximal length as measured from a proximal most end to a distal most end of the proximally directed member that is less than a proximal length of the ledges of the activator as measured from a proximal most end to a distal most end of the ledges (see annotated fig. 6b, the called out lengths are measured from the same distal most end point which is a flat plate from which the ledges 150 and arms 152 extend and the ledges are shown as having a greater length than the arms), and wherein the proximally directed member is designed to act on the distal end of the plunger rod for enabling movement in the proximal direction of the plunger rod and the actuator (see [0046]). Regarding claim 20, Hogdahl discloses the medicament delivery device wherein the guide rod is configured with fastening elements at its distal end (ledges 118, fig. 2) that engage cut-outs on the actuator (cut-outs 109, fig. 4; the claimed engagement is disclosed in [0036]). Regarding claim 21, Hogdahl discloses the medicament delivery device wherein the drive spring is arranged between a proximal end wall of the plunger rod and the fastening elements (the claimed proximal end wall is proximal wall 116; the claimed arrangement is disclosed in [0036]). Regarding claim 22, Hogdahl discloses the medicament delivery device further comprising a driver (holding element 66, fig. 4) operably connected between the plunger rod and a medicament container holder (medicament container holder 52, fig. 2; holding element 66 is operable connected between the elements as claimed as disclosed in [0042] and [0044] where it is operable connected to each of them and is shown as being longitudinally between the elements in figs. 1 and 3) such that movement of the plunger rod in the proximal direction will cause the driver and the medicament container holder to move in a proximal direction causing a penetration operation ([0048]). Regarding claim 23, Hogdahl discloses the medicament delivery device wherein the driver has a releasable connection to the plunger rod such that the plunger rod is released from the driver when a penetration operation has ended (see [0049]), enabling the plunger rod to continue in the proximal direction ([0049]), acting on a stopper of the medicament container (stopper 28, fig. 1 and [0049]) and causing an injection operation ([0049]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 15, 16, 18, and 24-25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Hogdahl (US 20180185583) as applied to claims 10 and 19 above, respectively. Regarding claims 15 and 24, Hogdahl discloses the medicament delivery device wherein the releasable connection comprises protrusions on an inner surface of the driver (ledges 74, fig. 5 and [0048]) cooperating with a recess on the plunger rod (see [0048], ledges 74 are in annular groove 122 which is a recess). Hogdahl additionally teaches that an equivalent embodiment of its medicament delivery device has a number of discrete recesses which replace a single recess on the plunger rod which is an annular groove ([0036]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have replaced the annular groove 122 of Hogdahl with a number of discrete recesses as Hogdahl teaches that such an embodiment is an art effective equivalent arrangement ([0036]) and thus such a substitution would have yielded the same, predictable result of protrusions on the inner surface of the driver cooperating with the exterior of the plunger rod (see Hogdahl [0048]). In the modified device, then, the longitudinal groove arranged in parallel with the longitudinal axis is one of these recesses as it would extend over a short length of the longitudinal axis. Regarding claims 16 and 25, Hogdahl as modified discloses the medicament delivery device wherein the longitudinal groove is aligned with the recesses (the hollow interior of plunger rod 112 is coaxial with the called out recesses and thus it is coaxially aligned therewith), wherein the longitudinal groove extends from the distal most end of the plunger rod to a certain distance from the recesses (see fig. 9, the hollow interior of plunger rod 112 extends from the distal most end of the plunger rod in the proximal direction to the longitudinal position of the recesses in the modified device, which is a certain distance from the recesses as claimed), and wherein the protrusions of the driver may slide into the recesses during the injection operation (see [0048] and [0036]). Regarding claim 18, Hogdahl discloses the medicament delivery device wherein the holding elements of the actuator comprise two proximally directed arms (flexible tongues 94, fig. 4) that are flexible in a generally radial direction ([0041]), in which the arms are arranged with inwardly directed arc-shaped protrusions (inwardly directed ledges 100, fig. 4) engaging a recess in the plunger rod (groove 122, fig. 2), and in which the arms are arranged with outwardly directed surfaces (transition surfaces 96 and the exterior of band-shaped part 98 as shown in fig. 4) engaging an inner surface of the actuator sleeve (see [0043]). Hogdahl additionally teaches that an equivalent embodiment of its medicament delivery device has a number of discrete recesses which replace a single recess on the plunger rod which is an annular groove ([0036]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have replaced the annular groove 122 of Hogdahl with a number of discrete recesses as Hogdahl teaches that such an embodiment is an art effective equivalent arrangement ([0036]) and thus such a substitution would have yielded the same, predictable result of protrusions on the inner surface of the driver cooperating with the exterior of the plunger rod (see Hogdahl [0048]). In the modified device, then, the longitudinal groove arranged in parallel with the longitudinal axis is one of these recesses as it would extend over a short length of the longitudinal axis. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Chu et al. (WO 2017191159) is considered relevant prior art where it teaches a longitudinal groove (28) extending along an exterior surface of a plunger rod (12) to provide a rotational lock between a plunger rod and a plunger rod holder (see pg. 8 lines 17-30). Any inquiry concerning this communication or earlier communications from the examiner should be directed to SAMUEL J MARRISON whose telephone number is (703)756-1927. The examiner can normally be reached M-F 7:00a-3:30p ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached on (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SAMUEL J MARRISON/Examiner, Art Unit 3783 /KEVIN C SIRMONS/Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 24 earlier events
Feb 27, 2026
Response after Non-Final Action
Apr 06, 2026
Non-Final Rejection mailed — §102, §103
Jun 08, 2026
Response Filed
Jun 24, 2026
Final Rejection mailed — §102, §103
Aug 14, 2026
Response after Non-Final Action
Aug 31, 2026
Request for Continued Examination
Sep 03, 2026
Response after Non-Final Action
Oct 27, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741132
ACCESS PORT
4y 3m to grant Granted Sep 22, 2026
Patent 12733976
DEVICES, SYSTEMS, AND METHODS FOR SIMULTANEOUS LIQUID INFUSION AND CATHETER MOTION
5y 3m to grant Granted Sep 15, 2026
Patent 12714802
AUTO INJECTOR WITH CASSETTE
4y 6m to grant Granted Aug 25, 2026
Patent 12708250
Medical Connecting Device
5y 3m to grant Granted Aug 18, 2026
Patent 12691225
Valve Stopper for a Medical Injection Device and Medical Injection Device for Injecting at Least One Composition
4y 11m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

9-10
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+35.7%)
4y 0m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 54 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month